1 insider bought €116k of shares over the last 90 days, the latest by Cush C. David, filed 22 Sept 2026.
+7 other insiders
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analysts rate Science Applications International Corp Hold (neutral), based on 9 analysts. Average price target: US$132.56.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended January 2026 · cache
25 of 920 declarations
At Science Applications International Corp, purchases are numerous and small: 46 worth EUR 3.6 million, with a median of EUR 38,227, against 64 sales worth EUR 37.5 million (median EUR 392,616). Purchases are 42% of open-market trades. From March 25 to April 14, 2025, 12 insiders bought for EUR 716,860, the widest window on file. Nazzic S. Keene (Chief Executive Officer) bought EUR 678,986 and then EUR 253,744 on April 3, 2020; Toni Townes-Whitley (Chief Executive Officer) bought EUR 292,646 on April 12, 2024.
The largest sales are by executives: Anthony J. Moraco (Chief Executive Officer) for EUR 3,474,052 and EUR 1,908,202 on April 4, 2018, and Nazzic S. Keene for EUR 2,548,318 on April 13, 2023. Of 45 purchases tracked to day 90, the stored median is -2.9%, positive in 40% of cases (past results as stored, not a forecast).
Nazzic S. Keene signs 111 filings, Anthony J. Moraco 104, Douglas Martin Wagoner (Sector President) 63, Michelle A. O'Hara (EVP, CHRO) 59 and Robert A. Bedingfield (Director) 48. The 678 grants make up most of the 920 filings from 45 filers. 2016 and 2017 each count 109 filings, 2021 only 62. Last twelve months: 48 filings, 7 purchases, no sale. Defense and aerospace, USD 5.7 billion.
Headquarters: Tysons, United States · Founded: 2013 · Wikipedia article
Source: Wikidata (CC0).
| Fiscal year end | Revenue | Net income | Diluted EPS | Dividend per share | Filing |
|---|---|---|---|---|---|
| Jan 2026 | 7.26 bn USD | 358.0 m USD | 7.70 USD | 0.37 USD | 10-K |
| Jan 2025 | 7.48 bn USD | 362.0 m USD | 7.17 USD | 0.37 USD | 10-K |
| Feb 2024 | 7.44 bn USD | 477.0 m USD | 8.88 USD | 0.37 USD | 10-K |
| Feb 2023 | 7.70 bn USD | 300.0 m USD | 5.38 USD | 0.37 USD | 10-K |
| Jan 2022 | 7.39 bn USD | 277.0 m USD | 4.77 USD | 0.37 USD | 10-K |
Amounts in USD, as filed (forms 10-K, 20-F or 40-F). Source: SEC EDGAR.